• 4125 Citations
  • 29 h-Index
1977 …2017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 6 Similar Profiles
Neoplasms Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Bone Neoplasms Medicine & Life Sciences
Cell Biology Medicine & Life Sciences
Thymoma Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Lung Medicine & Life Sciences
Femoral Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1977 2017

  • 4125 Citations
  • 29 h-Index
  • 92 Article
  • 4 Review article
  • 2 Comment/debate
  • 1 Letter
24 Citations (Scopus)
Adjuvant Chemotherapy
Non-Small Cell Lung Carcinoma
Drug Therapy
docetaxel
gemcitabine
3 Citations (Scopus)

Gene methylation biomarkers in sputum and plasma as predictors for lung cancer recurrence

Belinsky, S. A., Leng, S., Wu, G., Thomas, C. L., Picchi, M. A., Lee, S. J., Aisner, S., Ramalingam, S., Khuri, F. R. & Karp, D. D., Nov 1 2017, In : Cancer Prevention Research. 10, 11, p. 635-640 6 p.

Research output: Contribution to journalArticle

Sputum
Methylation
Lung Neoplasms
Biomarkers
Recurrence
5 Citations (Scopus)

Gene methylation biomarkers in sputum as a classifier for lung cancer risk

Leng, S., Wu, G., Klinge, D. M., Thomas, C. L., Casas, E., Picchi, M. A., Stidley, C. A., Lee, S. J., Aisner, S., Siegfried, J. M., Ramalingam, S., Khuri, F. R., Karp, D. D. & Belinsky, S. A., Jan 1 2017, In : Oncotarget. 8, 38, p. 63978-63985 8 p.

Research output: Contribution to journalArticle

Sputum
Methylation
Lung Neoplasms
Biomarkers
Genes
24 Citations (Scopus)

The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases

Thunnissen, E., Borczuk, A. C., Flieder, D. B., Witte, B., Beasley, M. B., Chung, J. H., Dacic, S., Lantuejoul, S., Russell, P. A., den Bakker, M., Botling, J., Brambilla, E., de Cuba, E., Geisinger, K. R., Hiroshima, K., Marchevsky, A. M., Minami, Y., Moreira, A., Nicholson, A. G., Yoshida, A. & 19 othersTsao, M. S., Warth, A., Duhig, E., Chen, G., Matsuno, Y., Travis, W. D., Butnor, K., Cooper, W., Mino-Kenudson, M., Motoi, N., Poleri, C., Pelosi, G., Kerr, K., Aisner, S., Ishikawa, Y., Buettner, R. H., Keino, N., Yatabe, Y. & Noguchi, M., Feb 1 2017, In : Journal of Thoracic Oncology. 12, 2, p. 334-346 13 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Differential Diagnosis
Immunohistochemistry
Neuroendocrine Carcinoma
Large Cell Carcinoma
35 Citations (Scopus)

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial

Neal, J. W., Dahlberg, S. E., Wakelee, H. A., Aisner, S., Bowden, M., Huang, Y., Carbone, D. P., Gerstner, G. J., Lerner, R. E., Rubin, J. L., Owonikoko, T. K., Stella, P. J., Steen, P. D., Khalid, A. A. & Ramalingam, S. S., Dec 1 2016, In : The Lancet Oncology. 17, 12, p. 1661-1671 11 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Therapeutics
cabozantinib
Erlotinib Hydrochloride
Disease-Free Survival